Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The compa...
Tenon Medical (TNON) experienced a spike and retreat during today's trading, primarily driven by pre-market news of FDA 510(k) clearance for its Catamaran SI Joint Fusion System, which sent the stock to an intraday high of $0.4750 before profit-taking pulled it back to close at $0.3177, flat vs. the prior close. Q1 revenue surged 89.94% YoY to $1.379 million, but net loss remained at $3.476 million with a net margin of -252.07%. The stock is currently 87.19% below its 52-week high of $2.48, down 67.38% YTD, and trades well below its 20-day ($0.519) and 60-day ($0.671) moving averages, though intraday volume reached 63.385 million shares, indicating strong market attention.
Tenon Medical Raises Capital, Regains Nasdaq Equity Compliance
Tenon Medical says $4.2M offering restores Nasdaq stockholders' equity compliance
Tenon Medical Hits Record Low After FDA Approval, Falls 8% After-Hours
Tenon Medical falls 3% during regular trading to $0.32
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System | TNON Stock News